This association could be due to the fact that drugs used to limit cardiovascular and cerebrovascular risk, such as ACE inhibitors and angiotensin II receptor blockers (ARBs), have numerous effects that could influence the susceptibility to or the severity of COVID-19. The gene discussed is ACE; the disease is COVID-19.